MCL1 and acute myeloid leukemia: With respect to the MCL-1 inhibitor S63845, we found that PL-21 and MOLM-16 cells were resistant with IC50 > 10 μM, while the other AML cell lines were susceptible with IC50 of 100–500 nM.